LONDON, April 1 PRNewswire/AsiaNet First Data On Novel Anti-Angiogenesis Drug Also Reported By AstraZeneca at AACR Meeting At the 95th annual American Association for Cancer Research (AACR)meeting in Orlando, USA, AstraZeneca Plc reported new gefitinib (IRESSA(tm),ZD1839) data exploring mechanisms of drug activity and resistance, as well asnew data relating to novel anti-angiogenesis drugs ZD6474 and AZD2171 thathave potential in a wide range of tumours. Furthering scientific understanding of
Korea's representative blockchain-based loyalty integration platform MiL.K, unlocks Indonesia market with GetPlus, a leading coalition loyalty program
—
Milk Partne...